Breaking News

Close

AstraZeneca PLC ADR (AZN)

	Symbol	Exchange	Currency
	AZN	NASDAQ	USD	Real-time
	AZNl	BATS Europe	GBP	Delayed
	AZNs	BATS Europe	SEK	Delayed
	AZNCF	OTC Markets	USD	Delayed
	3LAZ	London	GBP	Real-time
	3SAZ	London	GBP	Real-time
	AZN	London	GBP	Real-time
	AZNN	Mexico	MXN	Delayed
	AZNN	BIVA	MXN	Delayed
	AZN	Stockholm	SEK	Real-time
	AZN	Xetra	EUR	Delayed
	AZN	TradeGate	EUR	Delayed
	AZN	Frankfurt	EUR	Delayed
	AZNPy	Frankfurt	EUR	Delayed
	AZN	Buenos Aires	ARS	Delayed

Add to/Remove from Watchlist Add to Watchlist

72.52 +0.73 +1.02%

26/05 - Closed. Currency in USD ( Disclaimer )

After Hours

73.90

+1.38

+1.90%

19:41:34 - Real-time Data

Type: Equity

Market: United States

Volume: 3,449,742
Bid/Ask: 72.54 / 73.85
Day's Range: 72.31 - 72.90

AZN Income Statement

Featured here, the Income Statement (earnings report) for AstraZeneca PLC ADR, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Annual Quarterly

InvestingPro

Advanced Income Statement

Period Ending:

2023

31/03

2022

31/12

2022

30/09

2022

30/06

Total Revenue

10879

11207

10982

10771

Revenue	10879	11207	10982	10771
Other Revenue, Total	-	-	-	-

Cost of Revenue, Total

1773

2470

2041

1829

Gross Profit

9106

8737

8941

8942

Total Operating Expenses

8192

9539

8700

8750

Selling/General/Admin. Expenses, Total	4150	4661	4332	4616
Research & Development	2308	2472	2434	2417
Depreciation / Amortization	260	-4000	3437	283
Interest Expense (Income) - Net Operating	-365	-360	-339	-311
Unusual Expense (Income)	-	-	-	-
Other Operating Expenses, Total	66	3921	-3205	-84

Operating Income

2687

1668

2282

2021

Interest Income (Expense), Net Non-Operating

-

-

-

-

Gain (Loss) on Sale of Assets

241

-

-

-

Other, Net

184

750

1360

1774

Net Income Before Taxes

2262

778

922

247

Provision for Income Taxes

458

-124

-720

-113

Net Income After Taxes

1804

902

1642

360

Minority Interest

22

21

20

19

Equity In Affiliates

-

-

-

-

U.S GAAP Adjustment

-

-

-

-

Net Income Before Extraordinary Items

1803

901

1640

360

Total Extraordinary Items

-

-

-

-

Net Income

1803

901

1640

360

Total Adjustments to Net Income

-

-

-

-

Income Available to Common Excluding Extraordinary Items

1803

901

1640

360

Dilution Adjustment

-6.6

-3.22

3.05

1.2

Diluted Net Income

1809.6

904.22

1636.95

358.8

Diluted Weighted Average Shares

1560

1559

1559

1560

Diluted EPS Excluding Extraordinary Items

1.16

0.58

1.05

0.23

DPS - Common Stock Primary Issue

-

1.97

-

0.93

Diluted Normalized EPS

0.961

0.559

0.784

0.693

* In Millions of (except for per share items)

InvestingPro

Go to Dashboard InvestingPro

InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

AZN Comments

Write your thoughts about AstraZeneca PLC ADR

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Andre Van Laer Mar 23, 2023 2:29PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Why would anyone buy this thing...?

0 0

Neek Kajula Mar 24, 2022 9:36AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

did they develop a vaccine that works now or why is thos going up?

4 0

Hold This Sheet Sep 23, 2021 2:25PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Valneva

4 1

mudlog79 Sep 20, 2021 3:46PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

why this trash going up?

6 3

Pascal Torres Sep 20, 2021 3:46PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

speculation

0 0

Trader Global Sep 03, 2021 12:04AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

already breakout guy.

1 0

Adrian Vanyi Aug 09, 2021 2:45PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I would await some further drop based on the below article to come in the near future. The company did not perform well with the vaccine and i opened some short positions if my assumptions are correct.

0 0

Adrian Vanyi Aug 09, 2021 2:42PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

https://moneyweek.com/investments/stocks-and-shares/biotech-stocks/603675/astrazenecas-covid-troubles-could-see-it-pull

0 0

ray ford Jun 30, 2021 8:47AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

hold long = big victory ✌

5 0

Leo Mu Jun 28, 2021 3:49PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Finally it reached $60+.

2 0

Leo Mu Jun 24, 2021 9:39AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

AZN and MRK: Lynparza approved in China for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. Support is strong for the 2 stocks.

2 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200091293">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="200091293" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200091293" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200091293">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="233827346">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="233827346" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="233827346" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="233827346">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	33,117.0	+352.3	+1.08%
	US 500	4,211.0	+59.7	+1.44%
	Dow Jones	33,093.34	+328.69	+1.00%
	S&P 500	4,205.45	+54.17	+1.30%
	Nasdaq	12,975.69	+277.59	+2.19%
	S&P 500 VIX	17.95	0.00	0.00%
	Dollar Index	104.165	-0.010	-0.01%

	Crude Oil WTI	72.87	+1.04	+1.45%
	Brent Oil	76.98	+0.86	+1.13%
	Natural Gas	2.418	-0.058	-2.34%
	Gold	1,963.10	+2.40	+0.12%
	Silver	23.445	+0.535	+2.34%
	Copper	3.6723	+0.0843	+2.35%
	US Soybeans	1,336.25	+12.25	+0.93%

	U.S. 10Y	3.795	-0.012	-0.31%
	U.S. 30Y	3.969	-0.007	-0.17%
	U.S. 5Y	3.938	+-0.012	+-0.31%
	U.S. 3M	5.302	-0.020	-0.37%
	US 10Y T-Note	112.41	-0.21	-0.19%
	Euro Bund	133.34	+0.29	+0.22%
	10-2 Yield Spread	-76.02	-4.43	6.19%

	Apple	175.43	+2.44	+1.41%
	Alphabet A	124.61	+1.13	+0.92%
	Tesla	193.17	+8.70	+4.72%
	Amazon.com	120.11	+5.11	+4.44%
	Netflix	378.88	+19.88	+5.54%
	Meta Platforms	262.04	+9.35	+3.70%
	Bank of America	28.31	+0.14	+0.50%

Recent Quotes

	Name	Price	Chg.	Chg. %
	AZN	72.52	+0.73	+1.02%

	Name	Last	Chg. %	Vol.
	TSLA	193.17	+4.72%	160.68M
	AMZN	120.11	+4.44%	93.75M
	AMD	127.03	+5.55%	92.14M
	NVDA	389.46	+2.54%	71.06M
	AAPL	175.43	+1.41%	54.68M
	MSFT	332.89	+2.14%	35.72M
	META	262.04	+3.70%	25.22M

	Name	Last	Chg. %	Vol.
	MRVL	65.51	+32.42%	92.85M
	PDD	71.42	+18.99%	26.33M
	GPS	8.34	+12.40%	31.26M
	AVGO	812.73	+11.52%	7.93M
	WDAY	216.07	+10.01%	6.71M
	ANET	170.35	+9.06%	8.70M
	DLR	98.89	+7.23%	6.05M

	Name	Last	Chg. %	Vol.
	ULTA	420.27	-13.37%	6.07M
	KR	47.31	-3.25%	7.93M
	ES	68.69	-3.06%	3.84M
	RE	350.06	-2.75%	344.75K
	MDT	81.46	-2.49%	9.50M
	CTRA	24.24	-2.38%	7.30M
	CAH	82.83	-2.21%	1.94M